Literature DB >> 19164246

Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use.

Filip de Vin1, Peter Rutherford, Dirk Faict.   

Abstract

Peritoneal dialysis (PD) is an effective home-based therapy for end-stage renal failure. Intraperitoneal administration of drugs to PD patients is particularly important for the treatment of peritonitis. Clinicians need to know that the administered drug is compatible with both the PD solution and its container. A detailed literature search on drug compatibility and stability was performed and results of all published stability studies are presented for all drugs, PD solutions, and containers studied. These data will aid clinicians managing PD patients and provide a resource to demonstrate which drugs have been shown to be stable in various PD solutions and solution containers. This is important information to assist clinicians in applying effective treatments, in particular, for peritonitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19164246

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  17 in total

1.  Comparative in vitro antimicrobial activity of vancomycin, teicoplanin, daptomycin and ceftobiprole in four different peritoneal dialysis fluids.

Authors:  S Tobudic; W Poeppl; C Kratzer; A Vychytil; H Burgmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-19       Impact factor: 3.267

Review 2.  Peritoneal Dialysis-Associated Peritonitis.

Authors:  Cheuk-Chun Szeto; Philip Kam-Tao Li
Journal:  Clin J Am Soc Nephrol       Date:  2019-05-08       Impact factor: 8.237

3.  Standards of clinical practice for renal pharmacists.

Authors:  Colette B Raymond; Lori D Wazny; Amy R Sood
Journal:  Can J Hosp Pharm       Date:  2013-11

4.  Effect of glucose concentration on the stability of daptomycin in peritoneal solutions.

Authors:  Maria Asunción Parra; Miguel Angel Campanero; Belen Sádaba; Angel Irigoyen; Laura García-López; Maria Jose Fernandez-Reyes; Jose Ramon Azanza
Journal:  Perit Dial Int       Date:  2013 Jul-Aug       Impact factor: 1.756

5.  An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis.

Authors:  Martin Wiesholzer; Petra Pichler; Gottfried Reznicek; Michaela Wimmer; Manuel Kussmann; Peter Balcke; Heinz Burgmann; Markus Zeitlinger; Wolfgang Poeppl
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

Review 6.  Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.

Authors:  Bradley A Warady; Sevcan Bakkaloglu; Jason Newland; Michelle Cantwell; Enrico Verrina; Alicia Neu; Vimal Chadha; Hui-Kim Yap; Franz Schaefer
Journal:  Perit Dial Int       Date:  2012-06       Impact factor: 1.756

7.  Cephazolin and gentamicin are stable in lactate-buffered fresenius peritoneal dialysate for seven days at room temperature.

Authors:  Gillian K Balbir Singh; Martin J Wolley; Valmai C Laycock; David M Voss; Martin J Middleditch; Mark R Marshall
Journal:  Perit Dial Int       Date:  2014 Mar-Apr       Impact factor: 1.756

8.  Stability of the combination of ceftazidime and cephazolin in icodextrin or pH neutral peritoneal dialysis solution.

Authors:  Rahul P Patel; Madhur D Shastri; Mohammad Bakkari; Troy Wanandy; Matthew D Jose
Journal:  Perit Dial Int       Date:  2014-01-02       Impact factor: 1.756

9.  Vancomycin: the tale of the vanquisher and the pyrrhic victory.

Authors:  An S De Vriese; Stefaan J Vandecasteele
Journal:  Perit Dial Int       Date:  2014 Mar-Apr       Impact factor: 1.756

10.  Stability and Compatibility of Antibiotics in Peritoneal Dialysis Solutions Applied to Automated Peritoneal Dialysis in The Pediatric Population.

Authors:  Guillaume Deslandes; Matthieu Grégoire; Régis Bouquié; Aude Le Marec; Sophie Allard; Eric Dailly; Alain Pineau; Emma Allain-Launay; Pascale Jolliet; Gwenaëlle Roussey; Dominique Navas
Journal:  Perit Dial Int       Date:  2016-05-04       Impact factor: 1.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.